Uncategorized
Glaukos Announces Participation in Stifel 2017 Healthcare Conference
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that its management is scheduled to participate in the Stifel 2017 Healthcare Conference on Tuesday, November 14, 2017, at 10:15 a.m. EST in New York City. A live audio webcast for this event will be available in the Investors sect